- Q4 2023 PDS Biotechnology Corp Earnings Call TranscriptMar 27, 2024€4.13 (-4.95%)Earnings
- Q3 2023 PDS Biotechnology Corp Earnings Call TranscriptNov 14, 2023€4.85 (+7.55%)Earnings
- PDS Biotechnology Corp To Host Key Opinion Leader Roundtable TranscriptOct 03, 2023
- PDS Biotechnology Corp at Cantor Fitzgerald Global Healthcare Conference TranscriptSep 26, 2023
- Q2 2023 PDS Biotechnology Corp Earnings Call TranscriptAug 14, 2023€4.37 (-0.11%)Earnings
- PDS Biotechnology Corp To Host Post ASCO Call TranscriptJun 06, 2023
- Q1 2023 PDS Biotechnology Corp Earnings Call TranscriptMay 15, 2023€5.86 (-0.34%)Earnings
- PDS Biotechnology Corp To Host Key Opinion Leader Call TranscriptApr 21, 2023
- Q4 2022 PDS Biotechnology Corp Earnings Call TranscriptMar 28, 2023€5.37 (+0.75%)Earnings
- PDS Biotechnology Corp at Noble Capital Markets Takeaway Series on Channelchek- J.P. Morgan Healthcare Conference TranscriptJan 26, 2023
- PDS Biotechnology Corp Announces Exclusive Global License Agreement for Investigational IL-12 Tumor-Targeted Cytokine TranscriptJan 03, 2023
- Q3 2022 PDS Biotechnology Corp Earnings Call TranscriptNov 14, 2022€5.37 (-1.29%)Earnings
- PDS Biotechnology Corp Head And Neck Cancer KOL Roundtable TranscriptOct 26, 2022
- PDS Biotechnology Corp Update Call TranscriptAug 25, 2022
- Q2 2022 PDS Biotechnology Corp Earnings Call TranscriptAug 08, 2022€5.16 (+1.38%)Earnings
- PDS Biotechnology Corp Post ASCO Call TranscriptJun 07, 2022
- Q1 2022 PDS Biotechnology Corp Earnings Call TranscriptMay 11, 2022€4.18 (-1.90%)Earnings
- Q4 2021 PDS Biotechnology Corp Earnings Call TranscriptMar 31, 2022Earnings
- PDS Biotechnology Corp Extraordinary Shareholders Meeting TranscriptJan 19, 2022
- Q3 2021 PDS Biotechnology Corp Earnings Call TranscriptNov 10, 2021€8.84 (-4.93%)Earnings
- Q2 2021 PDS Biotechnology Corp Earnings Call TranscriptAug 12, 2021€8.93 (-2.75%)Earnings
- PDS Biotechnology Corp Oncology R&D Day TranscriptJun 16, 2021
- PDS Biotechnology Post-ASCO Conference Call - Corporate Analyst Meeting TranscriptJun 08, 2021
- Q1 2021 PDS Biotechnology Corp Earnings Call TranscriptMay 13, 2021€3.61 (+0.47%)Earnings
- Q2 2020 PDS Biotechnology Corp Earnings Call TranscriptAug 13, 2020€2.38 (-1.65%)Earnings
Q4 2023 PDS Biotechnology Corp Earnings Call Transcript
Good morning, and welcome to PDS Biotech's call to discuss the company's year-end 2023 financial results and clinical strategy update conference call. (Operator Instructions) I would now like to turn the conference over to Tom Johnson with LifeSci Advisors.
Please go ahead, sir.
Thank you, operator, and good morning, everyone, and welcome to PDS Biotech's 2023 year-end results and Clinical strategy update call. Today, we will discuss financial results for the year ended December 31, 2023, and provide a business and clinical programs update this morning, the company issued a press release with these results for GE found under the Investor Relations section of the PDS Biotech website.
I'm joined on the call today by the following members of the company's management team, Dr. Frank Bedu-Addo, Chief Executive Officer; Lars Boesgaard, Chief Financial Officer; and Dr. Kirk Shepard, Chief Medical Officer. Dr. Bedu-Addo will begin with a corporate and clinical programs update.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)